Form 4 for PRCT PROCEPT BioRobotics Corp
Accepted 2024-08-23 00:00:00 ET · period of report 2024-07-31 · accession 0001628280-24-038355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-23 | 2024-07-31 | PRCT | Zadno Reza | Pres, CEO, Dir | M - OptEx | $4.37 | +23.5K | 258.4K | +10% | +$102.6K |
| D | 2024-08-23 | 2024-07-31 | PRCT | Zadno Reza | Pres, CEO, Dir | M - OptEx | $0.00 | -23.5K | 1.25M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | M | A | 23,484 | $4.37 | 258,445 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-31 | M | D | 23,484 | $0.00 | 1,249,609 | D | $4.37 · — to 2030-02-19 | 23,484 Common Stock | (F1) The Stock Option was granted on February 20, 2020 and vested over a four year period. |